We are live on
!
Find out more
United Therapeutics
UTHR
UTHR
836 hedge funds and large institutions have $20.3B invested in United Therapeutics in 2025 Q4 according to their latest regulatory filings, with 200 funds opening new positions, 280 increasing their positions, 259 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
270% more first-time investments, than exits
New positions opened: 200 | Existing positions closed: 54
18% more funds holding
Funds holding: 707 → 836 (+129)
18% more capital invested
Capital invested by funds: $17.2B → $20.3B (+$3.12B)
11% more call options, than puts
Call options by funds: $390M | Put options by funds: $352M
6.09% more ownership
Funds ownership: 90.85% → 96.93% (+6.1%)
8% more repeat investments, than reductions
Existing positions increased: 280 | Existing positions reduced: 259
6% less funds holding in top 10
Funds holding in top 10: 17 → 16 (-1)
Holders
836
Holders Change
+129
Holders Change %
+18.25%
% of All Funds
10.17%
Holding in Top 10
16
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-5.88%
% of All Funds
0.19%
New
200
Increased
280
Reduced
259
Closed
54
Calls
$390M
Puts
$352M
Net Calls
+$38.4M
Net Calls Change
+$683M
Top Buyers
Top Sellers
| 1 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$318M |
| 2 |
Citigroup
New York
|
-$171M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
-$130M |
| 4 |
Renaissance Technologies
New York
|
-$123M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$113M |